Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9841071 | 0.96 | ADRA2A (0.32) | ADRA2AADRA1AMGAMGAASI | |
| SCHEMBL13144599 | 0.87 | PAM (0.32) | — | |
| SCHEMBL13010572 | 0.85 | NAAA (0.44) | ADRA2AADRA1AMGAMGAASI | |
| SCHEMBL2743953 | 0.85 | ALDH1A1 (0.46) | ADRA2AADRA1AMGAMGAASI | |
| SCHEMBL3702972 | 0.81 | — | — | |
| SCHEMBL243060 | 0.81 | ADRA2A (0.43) | ADRA2AADRA1AGAAMAPTBLM | |
| SCHEMBL8918587 | 0.81 | — | — | |
| SCHEMBL13949508 | 0.81 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL6683309 | 0.79 | ADRA2A (0.42) | ADRA2AADRA1AGAAMAPTBLM | |
| Ammonia Solution, Strong SCHEMBL2580733 | 0.79 | ADRA2A (0.42) | ADRA2AADRA1AGAAMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0138740-B1 | SYNTHETIC RESIN WOUND DRESSING AND METHOD OF MANUFACTURING | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1991-03-06 | — | — | EP | claimed |
| EP-0344090-A2 | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-11-29 | — | — | EP | claimed |
| US-4857334-A | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-08-15 | — | — | US | claimed |
| US-4747845-A | POLYACRYLATES OR POLYACRYLAMIDE WITH SOLVENT AND HYDROGEN BONDING PLASTICIZER | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1988-05-31 | — | — | US | claimed |
| US-4725271-A | POLYMER, SOLVENT, HYDROGEN BONDING PLASTICIZER; PREFORMED OR CURED IN SITU; TIMED RELEASE | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1988-02-16 | — | — | US | claimed |
| US-4563184-A | POLYHYDROXYETHYL METHACRYLATE, POLYOXYETHYLENE GLYCOL, PLASTICIZER | ENQUAY, INC. | 1986-01-07 | — | — | US | claimed |
| EP-0138740-A2 | Synthetic resin wound dressing and method of manufacturing | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1985-04-24 | — | — | EP | claimed |
| US-20240229242-A9 | Additive Solution-Processed Structural Colors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240133038-A1 | Additive Solution-Processed Structural Colors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-04-25 | — | — | US | disclosed |
| US-11802175-B2 | Epoxy resin modified with polyurethane in low concentration, production method therefor, epoxy resin composition, and cured object | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-10-31 | — | — | US | disclosed |
| US-11702502-B2 | Epoxy resin composition and cured product | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-07-18 | — | — | US | disclosed |
| US-20170198085-A1 | POLYURETHANE-MODIFIED EPOXY RESIN, METHOD FOR PRODUCING SAME, EPOXY RESIN COMPOSITION AND CURED PRODUCT | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| US-9345806-B2 | Manufacture of medical implants | SOLVAY SOLEXIS S.P.A. (IT) | 2016-05-24 | — | — | US | disclosed |
| WO-1996013248-A1 | INJECTION-MOLDED DOSAGE FORM | ALZA CORPORATION (US) | 1996-05-09 | — | — | WO | disclosed |
| EP-0390393-B1 | Polyglycolate peracid precursors and compositions containing them | CLOROX CO (US) | 1995-05-10 | — | — | EP | disclosed |
| US-5391812-A | Bleaching | THE CLOROX COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| US-5182045-A | Late peracid precursors | THE CLOROX COMPANY (US) | 1993-01-26 | — | — | US | disclosed |
| EP-0390393-A2 | Polyglycolate peracid precursors and compositions containing them | The Clorox Company (US) | 1990-10-03 | — | — | EP | disclosed |
| EP-0344090-A2 | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-11-29 | — | — | EP | disclosed |
| US-4857334-A | Synthetic resin matrix system incorporating healing enhancer | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1989-08-15 | — | — | US | disclosed |